King of Prussia, PA, United States of America

Xuan Hong

This inventor holds 2 USPTO granted patents. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuan Hong. Retrieved from https://idiyas.com/inventor/xuan-hong-01dfavtg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • King of Prussia, PA (US) (2021)
  • Collegeville, PA (US) (2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xuan Hong: Innovator in Antibody Engineering

Introduction

Xuan Hong is a prominent inventor based in King of Prussia, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody variants. With a total of 2 patents, his work focuses on enhancing the bioavailability of antibodies for therapeutic applications.

Latest Patents

Xuan Hong's latest patents revolve around innovative methods for selecting, screening, engineering, making, and modifying antibodies. These inventions aim to improve the bioavailability of antibodies upon subcutaneous administration to humans. His work not only describes the antibodies themselves but also the variant antibodies that exhibit enhanced bioavailability, which is crucial for effective treatment.

Career Highlights

Xuan Hong is associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in antibody engineering. His role in this esteemed company allows him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Xuan has collaborated with notable colleagues, including Valeriu Damian and Austin Keith Doyle. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their field.

Conclusion

Xuan Hong's contributions to antibody engineering exemplify the importance of innovation in biotechnology. His patents and collaborative efforts continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…